In vivo inhibition of antitumor immunity by embryonic antigens

The Fragility Index in peri-operative randomised trials that reported significant mortality effects in adults.

Anaesthesia·2019

The impact of non-blinding in critical care medicine trials.

Journal of critical care·2018

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Clonal analysis of the cytolytic T-cell response to human tumors.

Immunology today·2014

Allostimulation-induced tumor cytotoxic cells: from mouse to man.

Immunology today·2014

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma.

Tumori·2026

Beyond chemobrain: A stepwise approach to identifying cognitive impairment in non-CNS cancer survivors.

Tumori·2026

Quality of life in first-line trials for endometrial cancer: A systematic review.

Tumori·2026

Comparison of infusion-related reactions to chemotherapy versus targeted therapy: A four-year experience at the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori Milano.

Tumori·2026

Growth in oncology clinical trials and decline of independent research: Insights from the 22nd AIFA National Report on clinical trials.

Tumori·2026

Clinical and economic impact of community-based cancer care: Results from the S.M.A.R.T. Care Project in metastatic breast cancer patients.

Tumori·2026

The soluble HLA repertoire captures neoantigenic, cryptic, and tumour-associated peptides in melanoma.

Molecular & cellular proteomics : MCP·2026

Inflammatory Breast Cancer-The Evolution of Diagnosis and Modern Clinical Management.

JCO oncology practice·2026

Engineering Subcutaneous Ectopic Tertiary Lymphoid Structures as Personalized Immune-Activation Niches for Cancer Immunotherapy.

ACS applied bio materials·2026

Related Experiment Videos

In vivo inhibition of antitumor immunity by embryonic antigens

Related Concept Videos

The Fragility Index in peri-operative randomised trials that reported significant mortality effects in adults.

The impact of non-blinding in critical care medicine trials.

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.

Clonal analysis of the cytolytic T-cell response to human tumors.

Allostimulation-induced tumor cytotoxic cells: from mouse to man.

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma.

Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma.

Beyond chemobrain: A stepwise approach to identifying cognitive impairment in non-CNS cancer survivors.

Quality of life in first-line trials for endometrial cancer: A systematic review.

Comparison of infusion-related reactions to chemotherapy versus targeted therapy: A four-year experience at the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori Milano.

Growth in oncology clinical trials and decline of independent research: Insights from the 22nd AIFA National Report on clinical trials.

Clinical and economic impact of community-based cancer care: Results from the S.M.A.R.T. Care Project in metastatic breast cancer patients.

The soluble HLA repertoire captures neoantigenic, cryptic, and tumour-associated peptides in melanoma.

Inflammatory Breast Cancer-The Evolution of Diagnosis and Modern Clinical Management.

Engineering Subcutaneous Ectopic Tertiary Lymphoid Structures as Personalized Immune-Activation Niches for Cancer Immunotherapy.

Related Experiment Videos

In vivo inhibition of antitumor immunity by embryonic antigens

Related Concept Videos

Related Articles